Director, Institute of Molecular of Medicine, Peking University; Peking University Chair Professor. Research has been focused on cardiovascular and metabolic diseases, with a major emphasis on a translational approach to take bench discoveries into clinically relevant situations. Ongoing research directions include signalling pathways involved in metabolic syndrome and associated cardiovascular complications. Council Member, International Society of Heart Research. Associate Editor, New England Journal of Medicine. Member of multiple international journal editorial boards.